These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17728144)

  • 1. A hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate.
    Leong M; Babbitt W; Vyas G
    Biologicals; 2007 Oct; 35(4):227-33. PubMed ID: 17728144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection.
    Lai-Hipp C; Goldberg T; Scott E; Ziman A; Vyas G
    Transfusion; 2011 Feb; 51(2):333-7. PubMed ID: 20796251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human peripheral blood mononuclear cell substrate for propagating wild type HIV-1.
    Vyas GN
    Dev Biol (Basel); 2001; 106():345-56; discussion 356-7. PubMed ID: 11761248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of human immunodeficiency virus type 2 biological clones from peripheral blood lymphocytes.
    Blaak H
    Methods Mol Biol; 2005; 304():95-112. PubMed ID: 16061969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor.
    Toriniwa H; Komiya T
    Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
    Conceição MM; Tonso A; Freitas CB; Pereira CA
    Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymphocyte PEEK-WC hollow fiber membrane bioreactor.
    De Bartolo L; Piscioneri A; Cotroneo G; Salerno S; Tasselli F; Campana C; Morelli S; Rende M; Caroleo MC; Bossio M; Drioli E
    J Biotechnol; 2007 Oct; 132(1):65-74. PubMed ID: 17905461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
    Pan D; Whitley CB
    J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
    Steers NJ; Peachman KK; McClain S; Alving CR; Rao M
    Vaccine; 2009 Nov; 27(49):6939-49. PubMed ID: 19748578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale production of natural cytokines during activation and expansion of human T lymphocytes in hollow fiber bioreactor cultures.
    Lamers CH; Gratama JW; Luider-Vrieling B; Bolhuis RL; Bast EJ
    J Immunother; 1999 Jul; 22(4):299-307. PubMed ID: 10404431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical note on the isolation of HIV from peripheral lymphomonocytes: use of PHA].
    Fiore JR; Angarano G; Fico C; Fracasso C; Carbonara S; Pastore G
    Boll Soc Ital Biol Sper; 1990 May; 66(5):499-503. PubMed ID: 2397110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration.
    Subramanian S; Altaras GM; Chen J; Hughes BS; Zhou W; Altaras NE
    Biotechnol Prog; 2005; 21(3):851-9. PubMed ID: 15932265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
    Gramer MJ; Maas J
    Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.